KELOWNA, BC, Aug. 14, 2019 /PRNewswire/ - Valens GroWorks
Corp. (TSXV: VGW) (OTC: VGWCF) (the "Company" or
"Valens"), a vertically integrated provider of industry
leading extraction products and services; including a diverse suite
of extraction methodologies, next generation cannabinoid delivery
formats and an ISO 17025 accredited analytical lab, is pleased to
announce today that it has been added to The Cannabis ETF (NYSE:
THCX) ("THCX"), which trades on the New York Stock Exchange.
"Valens' inclusion in The Cannabis ETF will provide us with a
new opportunity to broaden our reach and increase our profile among
investors in the U.S. who are looking for the value our platform
provides, particularly as we continue to accelerate our business
activities globally" said Tyler
Robson, CEO of Valens
THCX tracks the Innovation Labs Cannabis Index, which is a
modified market capitalization weighted index, with a portfolio of
36 stocks that are expected to benefit from growth of the legal
marijuana, CBD and hemp industries. Valens' inclusion is part of
THCX's expansion to include various cannabis industry sub-themes,
such those at the crossroads of science and technology, which is
intended to appeal to investors who are looking for differentiated
exposure outside of a traditional seed-to-sale story. The index
rebalances on a monthly basis and it is currently considered the
lowest cost passively managed US-listed cannabis ETF.
About Valens GroWorks
Valens GroWorks Corp. (TSXV:VGW) (OTC:VGWCF) is a
multi-licensed, vertically-integrated cannabis company focused on
being the partner of choice for leading Canadian and international
cannabis brands by providing best-in-class, proprietary services
including CO2, ethanol, hydrocarbon, solvent-less and terpene
extraction, analytical testing, formulation and white label product
development. Valens is the largest third-party extraction
Company in Canada with an annual
capacity of 425,000 kg of dried cannabis and hemp biomass at our
purpose-built facility in Kelowna,
British Columbia which is in the process of becoming
European Union (EU) Good Manufacturing Practices (GMP)
compliant. Additionally, our subsidiary Valens Labs is a Health Canada licensed ISO
17025 accredited cannabis testing lab providing sector-leading
analytical services and has partnered with Thermo Fisher Scientific
to develop a Centre of Excellence in Plant-Based Science. For
more information, please visit http://valensgroworks.com. The
Company's investor deck can be found specifically at
http://valensgroworks.com/investors/
Notice regarding Forward Looking Statements
This news release contains certain "forward-looking statements"
within the meaning of such statements under applicable securities
law. Forward-looking statements are frequently characterized by
words such as "anticipates", "plan", "continue", "expect",
"project", "intend", "believe", "anticipate", "estimate", "may",
"will", "potential", "proposed", "positioned" and other similar
words, or statements that certain events or conditions "may" or
"will" occur. These statements are only predictions. Various
assumptions were used in drawing the conclusions or making the
projections contained in the forward-looking statements throughout
this news release. Forward-looking statements are based on the
opinions and estimates of management at the date the statements are
made and are subject to a variety of risks and uncertainties and
other factors that could cause actual events or results to differ
materially from those projected in the forward-looking statements.
The Corporation is under no obligation, and expressly disclaims any
intention or obligation, to update or revise any forward-looking
statements, whether as a result of new information, future events
or otherwise, except as expressly required by applicable law.
The TSXV or other regulatory authority has not reviewed,
approved or disapproved the contents of this press release. We seek
Safe Harbour.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/valens-added-to-nyse-listed-cannabis-etf-300901213.html
SOURCE Valens GroWorks Corp.
